Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Effects of SGLT2 inhibitors on cause-specific cardiovascular death in patients with chronic kidney disease: a meta-analysis of CKD progression trials.
Effects of SGLT2 inhibitors on cause-specific cardiovascular death in patients with chronic kidney disease: a meta-analysis of CKD progression trials. Clinical journal of the American Society of Nephrology : CJASN Fletcher, R. A., Herrington, W. G., Agarwal, R., Mayne, K. J., Arnott, C., Jardine, M. J., Mahaffey, K. W., Perkovic, V., Staplin, N., Wheeler, D. C., Chertow, G. M., Heerspink, H. J., Neuen, B. L. 2024View details for DOI 10.2215/CJN.0000000000000470
View details for PubMedID 38622766